[Prognosis determination in patients with malignant lymphoma].
One hundred and eight patients with malignant lymphoma were evaluated for pretreatment characteristics as potential predictors of response and survival. Age, sex, lymphocytes, lactic dehydrogenase, clinical evolution, histology, stage and initial symptoms provided the basis for a prognostic classification. The results show that the classification gives good information as the survival curves are clearly separated into three prognostic groups. Implications of the classification in therapy planning are briefly discussed.
Díaz-Maqueo
J C
JC
Avilés
A
A
Rodríguez
L
L
López-Vancell
D
D
García
E L
EL
Guzmán
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008223:Lymphoma / Q000188:drug therapy / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors
D007770:L-Lactate Dehydrogenase
Establecimiento de pronóstico en pacientes con linfoma maligno.